Clinical Trial

Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium

– Interim data from ongoing trial of PRT3789 showed additional clinical activity at higher doses in patients with non-small cell…

3 months ago

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

New clinical data from Phio's on-going Phase 1b trial to be presentedMarlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio…

3 months ago

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

New clinical data from Phio's on-going Phase 1b trial to be presentedMarlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio…

3 months ago

CASI Pharmaceuticals Receives CTA Approval From China’s NMPA for CID-103 in Immune Thrombocytopenia

BEIJING, CHINA / ACCESSWIRE / October 24, 2024 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development…

3 months ago

CASI Pharmaceuticals Receives CTA Approval From China’s NMPA for CID-103 in Immune Thrombocytopenia

BEIJING, CHINA / ACCESSWIRE / October 24, 2024 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development…

3 months ago

Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

REDWOOD CITY, CA / ACCESSWIRE / October 24, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the…

3 months ago

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform

New Ear Cytology protocol significantly improves veterinary practice workflow by reducing total time to perform common diagnostic procedure ANN ARBOR,…

3 months ago

Interim Report January-September 2024

GOTHENBURG, SWEDEN / ACCESSWIRE / October 24, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Third quarter 2024 (July 1 - September 30)•…

3 months ago

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development,…

3 months ago

EDETEK Launches CONFORM™ – ONCO+, a Therapeutic Area-Specific Accelerator for the CONFORM™ Platform

Unveiling AI-Driven Accelerators to Enhance Clinical Trial Efficiency and Precision PRINCETON, N.J., Oct. 23, 2024 /PRNewswire/ -- EDETEK Inc., a…

3 months ago